Stock ELEAF EL.EN. S.P.A.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings EL.En. S.p.A. OTC Markets

Equities

ELEAF

IT0005453250

Market Closed - OTC Markets
Other stock markets
 10:53:27 2024-02-01 am EST 		5-day change 1st Jan Change
9.8 USD +1.87% Intraday chart for EL.En. S.p.A. -.--% -22.14%
May. 16 Transcript : EL.En. S.p.A., Q1 2024 Earnings Call, May 16, 2024
May. 15 EL.En. S.p.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • The company is in a robust financial situation considering its net cash and margin position.
  • Analyst opinion has improved significantly over the past four months.
  • Over the past twelve months, analysts' opinions have been strongly revised upwards.
  • There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
  • For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
EL.EN. S.P.A. Stock EL.En. S.p.A.
-22.14% 864M -
SISRAM MEDICAL LTD Stock Sisram Medical Ltd
-35.93% 199M -
LAMEDITECH CO., LTD. Stock LAMEDITECH Co., Ltd.
0.00% 108M - -
LASEROPTEK CO., LTD. Stock Laseroptek Co., Ltd.
-26.21% 85.86M - -
MODULIGHT OYJ Stock Modulight Oyj
-3.75% 52.29M -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. ELN Stock
  4. ELEAF Stock
  5. Ratings EL.En. S.p.A.